JPRN-UMIN000027983
Completed
未知
Highly Active Antiretroviral Therapy and Cardiovascular Risk factor profiles of HIV-infected Subjects in Nigeria: a cross-sectional study - A risk prediction model for hypertension screening among HIV-positive Africans
niversity of Warwick Benue State University Teaching Hospital0 sites400 target enrollmentJuly 10, 2017
ConditionsHypertension
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- niversity of Warwick Benue State University Teaching Hospital
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •HIV negative Age below 18 years Presence of opportunistic infections Pregnant or lactating Inadequate adherence to regular visits at HIV clinic No consent provided.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Highly Active Antiretroviral Treatment (HAART) of Human Immunodeficiency Virus (HIV)-infection in a town in Cameroon: randomised controlled study to suggest which treatment starting point is most beneficial for the patientsHIV infectionInfections and InfestationsHIVISRCTN22114173Institute of Community Medicine, University of Tromsø (Norway)100
Completed
Not Applicable
Impact of highly active anti-retroviral therapy (HAART) during pregnancy and breastfeeding on mother-to-child transmission (MTCT) and mother's healthHuman immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)Infections and InfestationsHuman immunodeficiency virus (HIV)ISRCTN71468401World Health Organization (WHO) (Switzerland)2,400
Completed
Not Applicable
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
Completed
Not Applicable
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trialISRCTN48682427Ministry of Health (Brazil)
Active, not recruiting
Phase 1
Short pulse antiretroviral therapy at HIV seroconversion:A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection. Tratamiento antirretroviral en pulsos cortos en la seroconversión por el VIH: ensayo clínico aleatorizado, multicéntrico, de intervención terapéutica en la infección primaria por VIH-1. - SPARTACprimary HIV infection infección primaria por el VIHMedDRA version: 9.1 Level: LLT Classification code 10058427 Term: Primary HIV infectionEUCTR2004-000446-20-ESImperial College371